US Patent 11291667 Combination therapy involving diaryl macrocyclic compounds
Patent 11291667 was granted and assigned to Turning Point Therapeutics on April, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 25, 2018
Date of Patent
April 5, 2022
Patent Applicant
Patent Application Number
16480557
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11291667 Combination therapy involving diaryl macrocyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.